BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19193830)

  • 1. Evaluation of the combined application of ethanol-fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Papp M; Altorjay I; Lakos G; Tumpek J; Sipka S; Dinya T; Palatka K; Veres G; Udvardy M; Lakatos PL
    Clin Vaccine Immunol; 2009 Apr; 16(4):464-70. PubMed ID: 19193830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil fixation protocols suitable for substrates to detect anti-neutrophil cytoplasmic antibodies by indirect immunofluorescence.
    Nishibata Y; Matsuzawa S; Satomura Y; Ohtsuka T; Kuhara M; Masuda S; Tomaru U; Ishizu A
    Pathol Res Pract; 2021 Dec; 228():153661. PubMed ID: 34749213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study.
    Ooi CJ; Lim BL; Cheong WK; Ling AE; Ng HS
    Ann Acad Med Singap; 2000 Nov; 29(6):704-7. PubMed ID: 11269973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
    Radice A; Vecchi M; Bianchi MB; Sinico RA
    Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of unfixed and fixed human neutrophils for determination of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.
    Yang P
    J Clin Pathol; 1997 Aug; 50(8):677-80. PubMed ID: 9301553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of immunofluorescence to identification and characterization of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Bouzid D; Haddouk S; Amouri A; Ben Hadj Hmida Y; Tahri N; Masmoudi H
    Indian J Gastroenterol; 2011 Sep; 30(5):229-32. PubMed ID: 21986855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy.
    Terjung B; Worman HJ; Herzog V; Sauerbruch T; Spengler U
    Clin Exp Immunol; 2001 Oct; 126(1):37-46. PubMed ID: 11678897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual-fixed neutrophil substrate improves interpretation of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.
    Lin MW; Silvestrini RA; Culican S; Campbell D; Fulcher DA
    Am J Clin Pathol; 2014 Sep; 142(3):325-30. PubMed ID: 25125622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role.
    Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A
    Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel disease.
    Romas E; Paspaliaris B; d'Apice AJ; Elliott PR
    Aust N Z J Med; 1992 Dec; 22(6):652-9. PubMed ID: 1489288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
    Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
    Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical, cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
    Frenzer A; Fierz W; Rundler E; Hammer B; Binek J
    J Gastroenterol Hepatol; 1998 Sep; 13(9):950-4. PubMed ID: 9794196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.
    Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM
    Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value.
    Olives JP; Breton A; Hugot JP; Oksman F; Johannet C; Ghisolfi J; Navarro J; Cézard JP
    J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):142-8. PubMed ID: 9252899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha1-antitrypsin phenotypes and anti-neutrophil cytoplasmic auto-antibodies in inflammatory bowel disease.
    Taddei C; Audrain MA; Reumaux D; Sesboüe R; Testa A; Galmiche JP; Duthilleul P; Colombel JF; Esnault VL
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1293-8. PubMed ID: 10563543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing on formalin-fixed neutrophils is less sensitive and specific for small vessel vasculitis, and less sensitive for MPO-ANCA, than most ELISAs.
    Pollock W; Trevisin M; Savige J;
    J Immunol Methods; 2008 Dec; 339(2):141-5. PubMed ID: 18823991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate.
    Pollock W; Clarke K; Gallagher K; Hall J; Luckhurst E; McEvoy R; Melny J; Neil J; Nikoloutsopoulos A; Thompson T; Trevisin M; Savige J
    J Clin Pathol; 2002 Sep; 55(9):680-3. PubMed ID: 12194998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool.
    Montanelli A; Mainardi E; Vagni A; Villanacci V; Zambelli C; Cestari R; Cengia P; Minelli L; Missale G
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):201-7. PubMed ID: 15990710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
    Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
    J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.